Functional MRI data show that Sema alters activation in brain regions involved in reward and motivation, including the insula, putamen, and orbitofrontal cortex, which are associated with food cue reactivity and cravings
For obese populations with comorbidities such as type 2 diabetes, heart failure, and obstructive sleep apnea, it holds extensive therapeutic value
It sits between the other two on mechanism, covering GLP-1, GIP, and amylin while missing the glucagon arm
Wegovy and other medications containing Semagutide work by reducing your appetite
do not freeze) It's important to note that while dose titration and proper technique can reduce local and gastrointestinal side effects, they do not prevent true allergic reactions in susceptible individuals